Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pAG303-Gal-PR50 Citations (1)

Originally described in: Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.
Jovicic A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW 3rd, Sun S, Herdy JR, Bieri G, Kramer NJ, Gage FH, Van Den Bosch L, Robberecht W, Gitler AD Nat Neurosci. 2015 Sep;18(9):1226-9. doi: 10.1038/nn.4085.
PubMed Journal

Articles Citing pAG303-Gal-PR50

Articles
Upstream open reading frame with NOTCH2NLC GGC expansion generates polyglycine aggregates and disrupts nucleocytoplasmic transport: implications for polyglycine diseases. Zhong S, Lian Y, Luo W, Luo R, Wu X, Ji J, Ji Y, Ding J, Wang X. Acta Neuropathol. 2021 Dec;142(6):1003-1023. doi: 10.1007/s00401-021-02375-3. Epub 2021 Oct 25. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.